Impact Evaluation of Urban Water Supply Improvements on Cholera and Other Diarrhoeal Diseases in Uvira, Democratic Republic of Congo
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02928341 |
Recruitment Status :
Completed
First Posted : October 10, 2016
Last Update Posted : August 26, 2022
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Cholera Diarrhea | Other: Improved water supply | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 4556 participants |
Allocation: | Randomized |
Intervention Model: | Factorial Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Prevention |
Official Title: | Impact Evaluation of Urban Water Supply Improvements on Cholera and Other Diarrhoeal in Uvira, Democratic Republic of Congo |
Actual Study Start Date : | October 2016 |
Actual Primary Completion Date : | December 31, 2021 |
Actual Study Completion Date : | December 31, 2021 |

Arm | Intervention/treatment |
---|---|
No Intervention: No intervention
Current water supply access
|
|
Experimental: Intervention
Received water supply improvement intervention designed to improve access to tap water, consisting of community managed public taps, improved tap water distribution network, refurbished tap connections and promotion of new household tap connections.
|
Other: Improved water supply |
- Admission rate to the Uvira Cholera Treatment Centre [ Time Frame: 36 months ]
- Admission rate to the Uvira Cholera Treatment Centre of laboratory confirmed cholera cases [ Time Frame: 36 months ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | Child, Adult, Older Adult |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Uvira resident admitted to the Uvira Cholera Treatment Centre in Uvira
Exclusion Criteria:
- Any patients admitted during the period of intervention implementation in each cluster

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02928341
Congo, The Democratic Republic of the | |
Centre de Traitement du Cholera, Hôpital General de Reference d'Uvira, Sud-Kivu, République Démocratique du Congo | |
Uvira, Sud-Kivu, Congo, The Democratic Republic of the |
Principal Investigator: | Oliver Cumming, MSc | London School of Hygiene and Tropical Medicine | |
Principal Investigator: | Karin Gallandat, PhD | London School of Hygiene and Tropical Medicine |
Responsible Party: | London School of Hygiene and Tropical Medicine |
ClinicalTrials.gov Identifier: | NCT02928341 |
Other Study ID Numbers: |
8913 |
First Posted: | October 10, 2016 Key Record Dates |
Last Update Posted: | August 26, 2022 |
Last Verified: | August 2022 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Cholera Diarrhea Signs and Symptoms, Digestive Vibrio Infections |
Gram-Negative Bacterial Infections Bacterial Infections Bacterial Infections and Mycoses Infections |